Virus News and Research

Latest Virus News and Research

UK's most vulnerable will soon be able to access second ground-breaking antiviral

UK's most vulnerable will soon be able to access second ground-breaking antiviral

28 Jan 2022
Immuno-proteomic profiling suggests aberrant immune cell regulation associated with post-COVD-19 infection

Immuno-proteomic profiling suggests aberrant immune cell regulation associated with post-COVD-19 infection

28 Jan 2022
A synthesis of evidence sheds light on major immune components and mechanisms involved in COVID-19

A synthesis of evidence sheds light on major immune components and mechanisms involved in COVID-19

28 Jan 2022
Reduced neutralization against Omicron variant in fully immunized adolescents with BNT162b2 vaccine

Reduced neutralization against Omicron variant in fully immunized adolescents with BNT162b2 vaccine

28 Jan 2022
γ’ fibrinogen as a disease progression marker for COVID-19

γ’ fibrinogen as a disease progression marker for COVID-19

28 Jan 2022
In super-vaxxed Vermont, covid strikes — but packs far less punch

In super-vaxxed Vermont, covid strikes — but packs far less punch

28 Jan 2022
Potential therapy candidates for patients infected with the SARS-CoV-2 Omicron variant

Potential therapy candidates for patients infected with the SARS-CoV-2 Omicron variant

28 Jan 2022
Study demonstrates minimally invasive, aerosolized vaccine candidate to combat SARS-CoV-2

Study demonstrates minimally invasive, aerosolized vaccine candidate to combat SARS-CoV-2

28 Jan 2022
Magnetic nanoparticles for SARS-CoV-2 and other virus detection systems

Magnetic nanoparticles for SARS-CoV-2 and other virus detection systems

28 Jan 2022
Exploring receptor-blocking conserved non-neutralizing antibodies for SARS-CoV-2 therapy

Exploring receptor-blocking conserved non-neutralizing antibodies for SARS-CoV-2 therapy

28 Jan 2022
E406W mutation on SARS-CoV-2 RBD escapes monoclonal antibody cocktail-mediated neutralization

E406W mutation on SARS-CoV-2 RBD escapes monoclonal antibody cocktail-mediated neutralization

28 Jan 2022
Intranasal interferon-λ treatment protects mice against SARS-CoV-2 Beta and Omicron variants

Intranasal interferon-λ treatment protects mice against SARS-CoV-2 Beta and Omicron variants

28 Jan 2022
Airborne SARS-CoV-2 transmission beyond home isolation rooms may pose infection risk to others

Airborne SARS-CoV-2 transmission beyond home isolation rooms may pose infection risk to others

28 Jan 2022
New simulation model shows how likely the SARS-CoV-2 virus spreads in different school settings

New simulation model shows how likely the SARS-CoV-2 virus spreads in different school settings

28 Jan 2022
Pulse oximeters give false readings in a group of patients with COVID-19

Pulse oximeters give false readings in a group of patients with COVID-19

28 Jan 2022
New trial tests the effectiveness of hyperimmune immunoglobulin for hospitalized COVID-19 patients

New trial tests the effectiveness of hyperimmune immunoglobulin for hospitalized COVID-19 patients

28 Jan 2022
Researchers receive $3.7 million to identify reasons for higher rates of cancers, other diseases in HIV patients

Researchers receive $3.7 million to identify reasons for higher rates of cancers, other diseases in HIV patients

27 Jan 2022
SARS-CoV-2 virus may be shed for much longer periods by some infected patients, study shows

SARS-CoV-2 virus may be shed for much longer periods by some infected patients, study shows

27 Jan 2022
KHN’s ‘What the Health?’: Record ACA enrollment puts pressure on Congress

KHN’s ‘What the Health?’: Record ACA enrollment puts pressure on Congress

27 Jan 2022
Scientists identify immunogens that can elicit antibody responses against multiple SARS-CoV-2 variants

Scientists identify immunogens that can elicit antibody responses against multiple SARS-CoV-2 variants

27 Jan 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback